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Objective: Interpretation of lung perfusion scintigraphy in patients with suspected pul-
monary embolism (PE) is difﬁcult, especially in the presence of chronic obstructive
pulmonary disease (COPD) and most often has to be combined with pulmonary ventilation
scintigraphy. We investigated the data from the CT portion of pulmonary perfusion SPECT/
CT for possible resolution of this problem.
Methods: We assessed data from 12 patients (4 male, 8 female, mean age 68 y) with perfusion
defects, 6 with PE, 6 with COPD. Final interpretation was based on ventilation/perfusion (V/Q)
scintigraphy (mismatch or match). Lung tissue density was measured from the CT portion of
pulmonary perfusion SPECT/CT. We analyzed 32 areas in mismatch defects (PE), 25 areas in
match defects (COPD), and 17 areas without perfusion defects. Perfusion defects cause easily
identiﬁable on X-ray (e.g. effusion) were excluded from the analysis. Data were compared with
ANOVA test and Bonferroni post-hoc analysis, po0.05 was considered statistically signiﬁcant.
Results: The mean lung tissue density in areas without perfusion defects was 758 HU, in V/Q
mismatch defects (PE) 695 HU, and in V/Qmatch defects (COPD) 900 HU. The differences of
lung tissue density was statistically signiﬁcant (p¼0.000).
Conclusion: Lung tissue density measured by CT is signiﬁcantly lower in perfusion defects
caused by COPD than in those caused by PE. We believe this data could be used as an adjunct
in interpretation of pulmonary perfusion studies and potentially help avoid the performance
of ventilation scintigraphy in patients with suspected PE.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Pulmonary embolism (PE) is a common and potentially fatal
disease that can be treated efﬁciently if correctly diagnosed
within a short time of presentation [1]. The clinical diagnosisch Society of Cardiology.
86; fax: þ420 267162660.of PE is considered unreliable, as symptoms and signs are
variable [2,3]. Scintigraphic imaging of lung perfusion for
diagnosing PE has been employed for almost ﬁve decades [4].
Perfusion defect alone is nonspeciﬁc; up to 60% false-positive
results may occur in elderly patients, since obstructive airwayPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved..
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has been shown to improve speciﬁcity and can be implemen-
ted in most imaging departments with little additional
acquisition time or radiation dose [6,7].
The normal human lung is approximately 80% airspace
and 20% tissue and blood and CT densitometry studies have
shown that the normal human lung has a symmetrical
distribution of X-ray attenuation values around a mean of
approximately 800 Hounsﬁeld units (HU) [8]. It was found
that the extent of emphysema quantiﬁed pathologically was
directly correlated to lesser attenuation measured with a CT.
For CT scans emphysematous holes greater than 5 mm in
diameter correlated well with a threshold value of 910 HU.
Considering these information we investigated the lung
tissue density measured by the CT portion of pulmonary
perfusion SPECT/CT for possible increasing of the speciﬁcity
of perfusion defects interpretation. To our knowledge, this
has not been published in the scientiﬁc literature to date.2. Methods
We retrospectively analyzed data from 12 patients (4 male, 8
female), average age of 68 y, referred to our department forFig. 1 – (a) Example of mismatched defects on planar V/Q scintig
row ventilation. Views are from the left anterior, right posterior
(b) Example of matched defects on planar V/Q scintigraphy intelung perfusion scintigraphy with suspected pulmonary
embolism. All investigated patients had at least one perfu-
sion defect. 99mTc macro aggregated albumin (MAA) was used
for perfusion scintigraphy, 99mTc DTPA aerosol (ultrasound
nebulizer) was used for ventilation scintigraphy. Imaging was
performed with a hybrid gamma camera with non-diagnostic
four-slice CT (GE Inﬁnia Hawkeye). Planar images were
performed both for perfusion and ventilation; SPECT/CT was
performed for perfusion; SPECT alone was done for ventila-
tion. All images were acquired in the supine position during
normal breathing; CT was performed immediately after
perfusion SPECT. Planar perfusion images were performed
5 minutes after injection of 150 MBq of 99mTc MAA with a
high resolution collimator in a 128128 matrix. SPECT
images followed, they were acquired in a 128128 matrix
using a 3601 orbit, in 60 steps of 12 s each. CT scans were
acquired in a 512512 matrix, with a 2.5 mA current and
140 kV voltage, slice thickness 5 mm, pitch 1.9. Ventilation
images were obtained after inhalation of 1500 MBq of 99mTc
DTPA from ultrasonic nebulizer with the same parameters
as for perfusion. The ﬁnal decision regarding PE vs. COPD
was based mainly on ventilation/perfusion scintigraphy.
Mismatched defects were considered PE, matched defects
COPD (Fig. 1a and b) [5].raphy interpreted as PE. Upper row shows perfusion, lower
oblique, left posterior oblique and posterior aspect.
rpreted as COPD. Layout of the images is the same as in (a).
Fig. 2 – Example of ROIs drawing on the coronal (upper) and transversal (lower) slices. ROIs were drawn to leave out CT dense
structures (vessels, ﬂuid, ﬁssures and others).
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 9 2 – e 4 9 6e494Lung tissue density in the areas of normal perfusion and
in those of perfusion defects was measured from the CT
slices in HU. The CT scanner was subject to a daily quality
assessment with a phantom check including uniformity,
linearity, and noise. Air and water phantoms were used to
calibrate the CT scanner. Region of interest (ROI) technique
was used for measurement (Fig. 2). Irregular ROIs were used
on slices where perfusion defects were the best visible
(frontal and transversal slices) within the lung parenchyma
not associated with pathology easily recognizable on CT
(bullae, vascular structures or pleural effusion). We analyzed
17 areas without pathology, 32 mismatch perfusion defects,
and 25 match perfusion defects.We evaluated the statistical signiﬁcance of differences of
values from all three groups with ANOVA test for more
independent samples; we also provide Bonferroni post-hoc
testing to analyze differences between pairs of groups; p
values less than 0.05 were considered signiﬁcant. SPSS soft-
ware was used for calculations.3. Results
The mean lung tissue density in areas with normal perfusion
was 758 HU (SD 56, range from 842 to 652), in V/Q
mismatch perfusion defects 695 HU (SD 77, range from
Table 1 – Values of lung tissue density in HU on CT in normal lung tissue (NORM) and in V/Q mismatch and V/Q match
perfusion defects.
N Mean SD Min Max Sig.
NORM 17 758 56 842 652 0.000
V/Q mismatch 32 695 77 829 516 0.000
V/Q match 25 900 48 973 802 0.000
Table 2 – Bonferroni post-hoc analysis of differences
in lung tissue density (abbreviations as in Table 1).
Mean difference Std. error Sig.
NORM
V/Q mismatch 63 19 0.005
V/Q match 141 20 0.000
V/Q mismatch
V/Q match 204 17 0.000
Fig. 3 – Comparison of lung tissue density measured by
Hawkeye CT in normal lung parenchyma and in V/Q match
(COPD) and V/Q mismatch (PE) defects: a box-plot.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 4 9 2 – e 4 9 6 e495829 to 516), and in V/Q match perfusion defects 900 HU
(SD 48, range from 973 to 802) (Table 1). All the densities
differed signiﬁcantly (p¼0.000). Post-hoc analysis conﬁrmed
that densities differed signiﬁcantly among all groups (Table 2,
Fig. 3).4. Discussion
The concept of ventilation/perfusion (V/Q) mismatch is the
underlying principle of V/Q scintigraphy, which has been
extensively used for PE evaluation for many decades [5–7] and
modiﬁed PIOPED criteria are still used for the determination
of the probability of PE [9]. The main PIOPED critiques deals
with the large number of indeterminate interpretations,
which were related to the study population of inpatients
with a high incidence of cardiopulmonary diseases [10]. There
are also PISA-PED criteria for interpretation of perfusionscintigraphy alone, which take into account possible chest
radiographic abnormalities [11,12]. The authors undertaken
that the chest radiograph is not to be used as a surrogate for
the ventilation scan. This statement, however, was derived
from a planar scintigraphy and a planar radiograph, but we
used tomographic imaging of both and moreover we quanti-
ﬁed the lung tissue density.
There are a huge number of literatures about CT pulmon-
ary angiography during the last decade [13]. Most reports
have focused on vessel size and on detection of intraluminal
thrombus but did not discuss parenchymal abnormalities.
Introduction of hybrid imaging devices improved diagnostic
performance of scintigraphy mainly by detecting other causes
of perfusion defects (maintained sensitivity and improved
speciﬁcity) [14].
Lung perfusion scintigraphy can in fact be abnormal in a
variety of conditions, like compression or invasion of pul-
monary vessels by tumors, emphysema (especially in bullous
disease), interstitial ﬁbrosis, bronchiectasis, pneumonic con-
solidation and atelectasis, effusions, localized bronchial
obstruction, vasculitis, arteriovenous ﬁstulae, etc [15], but in
fact, COPD is the most frequent one, especially in elderly [5].
Low-dose CT is able to characterize pulmonary vessels and
ﬁssures that can result in defects on perfusion scintigraphy
and was proven to detect also other pathologic conditions,
such as emphysematous bullae, pneumonia, atelectasis, and
pleural ﬂuid [6]. All these conditions were excluded using
Hawkeye CT before analysis of data in our patients.
Most changes in diseases that primarily affect air ﬂow in
the alveolar space are due to intrapulmonary adaptation
mechanisms whereby blood ﬂow is diverted from poorly
ventilated to better ventilated spaces in order to optimize
the V/Q ratio, and therefore to maximize respiratory gas
exchanges. Conversely, within a few hours of blood ﬂow
obstruction other intrapulmonary adaptation mechanisms
start diverting air ﬂow from unperfused to perfused lung
zones, thus avoiding ventilation of areas where respiratory
gas exchanges cannot occur. While early after embolism
these mechanisms may be linked to local bronchoconstric-
tion caused by hypocapnia, reduced production of surfactant
distal to embolism (with ensuing shrinkage of the alveolar
space in the unperfused region) is the most important
mechanism taking place more slowly, within 18–24 h [15].
The rationale for our investigation was the fact that the
aforementioned changes in the quantity of tissue and gas in
the lung causes changes in the distribution of X-ray attenua-
tion values [8]. The root cause of COPD is an exaggerated
inﬂammatory response that, in susceptible people, results in
a destruction of lung tissue (emphysema). It implies that the
lung tissue density was different (lower) comparing to the
normal tissue or the tissue behind the embolus.
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abnormalities on the basis of changes in lung attenuation in
patients with pulmonary emboli has not been systematically
assessed, to our knowledge. We found increased attenuation
in the regions of V/Q mismatch perfusion defects (interpreted
as caused by PE) in our patients. It is consistent with
pathophysiological changes which take place behind embo-
lism and cause decreased aeration of lung tissue [15]. On the
other hand we found much lower attenuation in the perfu-
sion defects, where ventilation defects were also present
(interpreted as caused by COPD). It is again consistent with
anatomical and functional changes (alveolar parenchyma
destructive alterations with increased residual volume – air
trapping) mostly found in COPD [16].
There are two approaches to clinical SPECT/CT applica-
tions: the ﬁrst approach is the use of a low-output, slow
acquisition CT scanner, which was used by us, while the
other incorporates commercially available diagnostic helical
CT scanners [6]. Nevertheless all these systems can be also
used for attenuation correction and tissue density measure-
ment using low dose parameters. The main advantage is
much lower radiation and no contrast media [10].
We can conclude, that lung tissue density measured by CT
is signiﬁcantly lower in V/Q match defects (interpreted as
COPD) than in V/Q mismatch defects (interpreted as PE,
where the density is even slightly higher than in normal
tissue), and the overlap of values is minimal. We were able to
interpret all patients equally as with V/Q scintigraphy using
this parameter.
Based on our preliminary data, we believe that the
quantitative analysis of lung tissue density in the perfusion
defect areas in patients worked up for suspected pulmonary
embolism could avoid the necessity to perform ventilation
scintigraphy especially in patient in whom COPD must be
taken into consideration.
Low-dose CT as a part of hybrid device is readily available
and does not increase radiation so much. It can also shorten
examination time of breathless patients.
However, our group of patients is too small so the efﬁcacy
of such an approach must be conﬁrmed by analyzing a larger
group of patients.Acknowledgments
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